CODEXIS INC

CDXS refers to the common stock of Codexis, Inc., a biotechnology company. The ticker trades on the Nasdaq Global Market under the symbol CDXS. The company focuses on developing enzymes and proteins used in pharmaceutical manufacturing and other industrial applications. As a stock, CDXS represents an ownership stake in Codexis, meaning its price and performance are tied to the company's business results and broader market sentiment.

The 52-week range shows the lowest and highest prices at which CDXS has traded over the past year. It is a common reference point for assessing where the current price sits relative to recent extremes. Because this figure changes with market activity, the exact range for CDXS should be checked using the latest quote data displayed on this page.

Evaluating CDXS often involves looking beyond standard earnings-based metrics, since biotechnology companies may have irregular or negative profits. Investors frequently review price-to-sales, price-to-book, cash balances, and pipeline progress. Comparing these measures with peers in the life sciences tools and biotech sector can provide context. The latest valuation ratios for CDXS are available in the financial data section on this page.

To buy CDXS stock, you generally need a brokerage account that offers access to U.S. markets. Once funded, you can place a market or limit order for CDXS shares during regular trading hours. Some brokers also support extended-hours trading and fractional shares, subject to their policies. Confirm any commissions, fees, and order types before submitting a trade.

Codexis has historically not paid regular cash dividends on its common stock. Instead, the company has focused on reinvesting capital into its business and research activities. Whether CDXS pays dividends in the future depends on its financial position and board decisions. For the most current dividend status, check the dividend information shown on this page.

Analyzing CDXS typically involves reviewing revenue trends, gross margins, operating expenses, and cash flow. Key filings such as the annual 10-K and quarterly 10-Q provide detailed financial statements. Tracking changes in product revenue, research collaborations, and cash burn can help investors understand the company's trajectory. Updated financial highlights for CDXS are available on this page.